Correlation of Viral Load With the Clinical and Biochemical Profiles of COVID-19 Patients.

clinical severity covid-19 cycle threshold rt-pcr sars-cov-2 viral load

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
Jul 2021
Historique:
accepted: 27 07 2021
entrez: 31 8 2021
pubmed: 1 9 2021
medline: 1 9 2021
Statut: epublish

Résumé

Background/objective Coronavirus infectious disease (COVID-19) is a novel disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-COV-2). Some studies have shown that disease severity according to clinical and biochemical parameters are in direct relation to viral load while others have found no direct correlation. In this study, the COVID-19 cycle threshold (Ct) value, which is taken as a direct indicator of the viral load, has been correlated with the biochemical and clinical parameters in COVID-19 patients. Methods In this cross-sectional, retrospective, and single-center study, 365 patients admitted with COVID 19 were divided into three groups according to their Ct values obtained from reverse transcription-polymerase chain reaction RT-PCR as 1 (9-20), 2 (21-30), and 3 (31-40). The correlation of the COVID-19 Ct value with biochemical parameters and clinical presentation (taken as mild, moderate, and severe) was done and analyzed. The chi-square test was used for the correlation and calculated by using SPSS V-24.0 (IBM Corp., Armonk, NY). p-value <0.05 was considered significant statistically. Results Disease severity levels (mild, moderate, and severe) correlated in group 1 (Ct value 9 to 20), 2 (Ct value 21 to 30), and 3 (Ct value 31 to 40) but no significance was found between disease severity levels and the Ct value groups' p-value (>0.05). All the biochemical parameters analyzed (alanine transaminase (ALT), aspartate aminotransferase (AST), albumin, bilirubin, c-reactive protein (CRP), lactate dehydrogenase (LDH), ferritin, D-dimer, and total leucocyte count (TLC)) showed a significant p-value (<0.05) in all the three groups studied. Procalcitonin (PCT), however, did not show any significant value in any of the groups studied. In the intergroup assessment, it was found that the values of ALT, AST, albumin, CRP, ferritin, bilirubin, and TLC are maximum in group 2 with a downward trend in groups 1 and 2. Neutrophils and lymphocytes did not show any variations. LDH did not follow the trend of increasing viral load. Conclusions The severity of the disease was not statistically significant in the Ct value groups (p> 0.05). However biochemical parameters, i.e. ALT, AST, ALP, CRP, and bilirubin were statistically significant (p<0.05). Patients with COVID-19 should be closely monitored for the assessment of disease progression according to the above-mentioned biochemical parameters.

Identifiants

pubmed: 34462686
doi: 10.7759/cureus.16655
pmc: PMC8388060
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e16655

Informations de copyright

Copyright © 2021, Atique et al.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Lancet Gastroenterol Hepatol. 2020 May;5(5):428-430
pubmed: 32145190
Intensive Care Med. 2015 Oct;41(10):1739-51
pubmed: 26194026
Liver Int. 2020 Jul;40(7):1787-1788
pubmed: 32304343
J Infect. 2020 Apr;80(4):388-393
pubmed: 32112884
J Thromb Haemost. 2020 Jun;18(6):1324-1329
pubmed: 32306492
Travel Med Infect Dis. 2020 Mar - Apr;34:101623
pubmed: 32179124
Clin Infect Dis. 2021 Apr 26;72(8):1489-1490
pubmed: 32562539
Intensive Care Med. 2002 Sep;28(9):1220-5
pubmed: 12209268
Trends Microbiol. 2016 Jun;24(6):490-502
pubmed: 27012512
J Med Virol. 2020 Sep;92(9):1533-1541
pubmed: 32181903
Biomark Med. 2020 Jul;14(10):827-837
pubmed: 32490680
Asia Pac J Public Health. 2020 May;32(4):154-156
pubmed: 32429679
Infect Dis Ther. 2020 Sep;9(3):573-586
pubmed: 32725536
Clin Infect Dis. 2020 Jul 28;71(15):793-798
pubmed: 32221523
Indian J Clin Biochem. 2021 Apr 23;:1-12
pubmed: 33907355
Clin Chim Acta. 2020 Nov;510:170-176
pubmed: 32659224
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Diagnostics (Basel). 2021 Jun 15;11(6):
pubmed: 34203738
PLoS One. 2018 Nov 14;13(11):e0206527
pubmed: 30427887
PLoS One. 2016 Mar 03;11(3):e0150269
pubmed: 26937636
Pak J Med Sci. 2019 Jul-Aug;35(4):1030-1035
pubmed: 31372137
Lancet. 2020 Feb 15;395(10223):507-513
pubmed: 32007143
Arch Acad Emerg Med. 2020 Apr 4;8(1):e43
pubmed: 32259132
Am J Transplant. 2002 Nov;2(10):970-4
pubmed: 12482151

Auteurs

Muhammad Atique (M)

Histopathology, Pakistan Kidney and Liver Institute & Research Center, Lahore, PAK.

Atif Ghafoor (A)

Molecular Biology, Pakistan Kidney and Liver Institute & Research Center, Lahore, PAK.

Rabia Javed (R)

Histopathology, Pakistan Kidney and Liver Institute & Research Center, Lahore, PAK.

Noor Fatima (N)

Molecular Biology, Pakistan Kidney and Liver Institute & Research Center, Lahore, PAK.

Anam Yousaf (A)

Molecular Biology, Pakistan Kidney and Liver Institute & Research Center, Lahore, PAK.

Samana Zahra (S)

Molecular Biology, Pakistan Kidney and Liver Institute & Research Center, Lahore, PAK.

Classifications MeSH